Clinical trial

Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis

NCT03478033

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2018-04-15

PhaseNA

Study timeline

Study start (actual)2018-04-15Date precision: day

Registry last updated2018-04-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Tuberculosis, Pulmonaryunresolved

AIDSunresolved

Interventions

Sponsors & collaborators

Shanghai Public Health Clinical Centerlead sponsor

The Guangxi Zhuang Autonomous Region Longtan hospitalcollaborator

The Fourth People's Hospital of Nanningcollaborator

Shenzhen Third People's Hospitalcollaborator

Yunnan Provincial Infectious Disease Hospitalcollaborator

Zhejiang Universitycollaborator

Chongqing Public Health Medical Centercollaborator

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03478033 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.